Skip to main content

Adicet Bio, Inc.

ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001720580

No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Adicet Bio, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ACET: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders10795−12
Shares40.3M37.2M−3.10M (−7.7%)
Value$231.3M$90.4M−$140.9M (−60.9%)

New holders (19)

Institutions that held Adicet Bio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ACET in Q2 2023
InstitutionSharesValue% of portfolio
Norges Bank429,550$1.04M0.00%
Two Sigma Investments, LP154,633$375.8K0.00%
Occudo Quantitative Strategies LP143,540$348.8K0.04%
Prudential Financial Inc59,650$144.9K0.00%
Cornercap Investment Counsel Inc38,690$94.0K0.02%
Ameriprise Financial Inc33,520$81.5K0.00%
Exchange Traded Concepts, LLC29,490$71.7K0.00%
Y-Intercept (Hong Kong) Ltd26,892$65.3K0.01%
Acadian Asset Management LLC22,914$54.0K0.00%
Two Sigma Securities, LLC18,207$44.2K0.00%
Schonfeld Strategic Advisors LLC17,300$42.0K0.00%
Virtu Financial LLC16,097$39.0K0.00%
Walleye Capital LLC10,002$24.3K0.00%
Summit Trail Advisors, LLC10,000$24.3K0.00%
The PNC Financial Services Group, Inc.1,400$3.40K0.00%
Red Tortoise LLC649$1.58K0.00%
Federated Hermes, Inc.284$6900.00%
Impact Partnership Wealth, LLC67$1630.00%
UBS Group AG27$660.00%

Sold out (31)

Institutions that held Adicet Bio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.